This article, written by Dr. Peter Hotez, president of Sabin Vaccine Institute and dean of the National School of Tropical Medicine at Baylor College of Medicine, originally appeared in TAMEST (The Academy of Medicine, Engineering and Science of Texas) e-news.

Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.

Sabin Vaccine Institute President Dr. Peter Hotez is leading the research at Texas Children’s Hospital and Baylor College of Medicine to develop the first-ever vaccine for Chagas disease.

Dr. Peter Hotez, president of the Sabin Vaccine Institute, was honored last week with the prestigious Abraham Horwitz Award for Excellence in Inter-American Public Health.

A midweek review of vaccine research and advocacy efforts in the news:

ABC News posted a video Thursday entitled “Parasitic Worms,” which features Sabin Vaccine Institute’s Dr. David Diemert discussing Sabin Vaccine Development work in Minas Gerais, Brazil. The video, which was produced in 2010 by Rockhopper, highlights the pervasiveness of hookworm infection among children in Brazil.

Pages

Subscribe to RSS - Sabin Vaccine Development